TBS has assembled a management team and business and scientific advisory boards with extensive relevant experience and a track record of business success.

Thomas J. Dee
CEO
Tom has over 30 years of business experience, nearly 26 years of which were with Ionics, Inc. At Ionics Tom  provided international sales support for over $100 million of water treatment projects, built a bottled water delivery business from inception to 100,000 customers, and concluded 11 acquisitions. The business was sold to Perrier for $220 million. Tom also worked with all senior management providing strategic assessments of technology, licensing opportunities, acquisitions and business modeling of complex BOO (Build-Own-Operate) projects. Ionics was acquired by General Electric for $1.3 billion.

George J. Vella, PhD
CTO
(Acting)
George has over 30 years of research and business experience identifying and bringing disruptive technologies to the Life Sciences market. He brings Life Sciences product development expertise, a customer point of view and business development experience to complement the engineering efforts to develop novel and differentiated commercial products. His expertise includes R&D management and strategic business planning, overseeing the commercialization of several enabling technologies from idea to product introduction. His Life Sciences experience includes serving as Vice President of R&D (BioProcessors), Divisional Vice President of Science and Technology and Scientific Fellow (Applied Biosystems), Vice President of Chemical R&D and Technical Affairs (PerSeptive Biosystems), Director of Research & Strategic Planning (Charley’ Fund Inc), a patient advocacy organization bringing two drugs to human clinical trials for Duchenne Muscular Dystrophy (DMD), a rare genetic disease, and  various senior management positions at Millipore/Waters Corporation. He received his PhD in Bio-Organic Chemistry from McMaster University and he was a Post Doctoral Fellow at the Biochemistry Research Institute at the Hospital for Sick Children in Toronto, and then joined the staff of the Cardiovascular Research Focus Group as a Senior Investigator. George was a member of several scientific advisory boards including two DMD therapeutic start-up companies and NIH funded drug development projects. He is a member of the Massachusetts Life Science Center and NIH SBIR/STTR grant review board. He also mentors non-profit organizations on best practices in forging strategic alliances with the Biotech and Pharmaceutical industries.

Morton Rosenberg
CFO (part time)
Financial, Administrative and Systems Executive during the last 30 years in a variety of industries including an office products distribution, sheet metal fabrication, a development stage fuel cell company, software developer, manufacturer of woolen products, investment management company, real estate management company and a construction company.

View our Advisory Board

home  |   applications  |   product info  |   management   |   about (ClO2)   |   news & info   |   contact